Bloodstream infection is the most common infectious complication in hematopoietic cell transplantation 13 recipients. To evaluate the genomic concordance of bloodstream pathogens and bacterial strains within 14 the intestinal microbiome using whole genome sequencing, we developed StrainSifter, a bioinformatic 15 pipeline to compare nucleotide variation between bacterial isolate strains and stool metagenomes. We 16 applied StrainSifter to bloodstream isolates and stool metagenome samples from hematopoietic stem cell 17 transplant recipients with bloodstream infections. StrainSifter is designed to identify single nucleotide 18 variants between isolate and metagenomic short reads using stringent alignment, coverage, and variant 19 frequency criteria for strain comparison. We identified enteric BSI isolates that were highly concordant 20 with those in the gut microbiota, as well as highly concordant strains of typically non-enteric bacteria. 21
Introduction 26
Microbial pathogenicity and transmission depend in part on strain-level variability in both gene content 27 and at the single-nucleotide variant (SNV) level, as different strains of the same organism can vary widely 28 in their ability to cause disease (Snitkin et al. 2011; Lieberman et al. 2013 ). Whole genome sequencing 29 (WGS) has facilitated the exploration of strain-level determinants of virulence and has enabled the precise 30 Despite the increasing use of WGS for strain comparison, bioinformatic tools have not been developed for 42 the specific purpose of comparing disease-causing bacterial isolates to metagenomic samples at the 43 nucleotide level within the same patient. It is desirable to achieve the highest resolution of comparison 44 across the whole genome of an organism in order to precisely compare clinical isolates to strains within a 45 sampled metagenome. Additionally, most tools depend on the availability of reference genomes and are 46 thus often restricted to studying well characterized bacterial pathogens, limiting the types of organisms 47 that are available for strain comparisons. To date, no reference-free tool exists with the stringent filtering 48 steps necessary to identify genomic variants specific to a single strain between genomes and 49 metagenomes. We sought to compare strain-level identity between bloodstream infection isolates and including intravenous lines and sites where skin epithelial integrity has become compromised. Existing 62 methods for strain comparison have been helpful in identifying the origins of bloodstream infections in 63 HCT patients using culture-based pulsed-field gel electrophoresis (PFGE), or PCR-based multi-locus 64 sequence typing (MLST) (Tancrede and Andremont 1985; Samet et al. 2013) . Although these methods 65 are rapid, affordable, and standardized across many organisms, they have several limitations: 1) they 66 require isolation and culture of candidate pathogens from the stool or other suspected pathogen reservoirs, 67 a step that can introduce selection bias, and 2) they often rely on detailed characterization of a small 68 number of genes and therefore lack the discriminatory power required for robust, genome-wide strain 69 comparison (W. Li, Raoult, and Fournier 2009) . No studies to date have investigated the origins of 70 bloodstream infections in HCT or other immunocompromised patients at the level of single nucleotide 71 variation across entire genomes. 72
73
In this work, we present StrainSifter, a straightforward bioinformatics pipeline based on whole genome 74 sequencing to comprehensively and precisely compare single nucleotide variants between isolate 75 genomes and metagenomes without bias introduced by culturing. Additionally, unlike most previous 76 strain comparison bioinformatic tools (MIDAS and StrainPhlAn), variant calling within our pipeline does 77 not depend on the availability of a reference genome database, a particularly relevant consideration in 78 immunocompromised patients who develop infections with lesser known and poorly studied opportunistic 79 pathogens. We have applied this tool to track bacterial strain translocation from the gut to the bloodstream 80 in a unique cohort of immunocompromised patients at high risk for translocation and bloodstream 81 infection, specifically patients with hematologic malignancies who have undergone hematopoietic stem 82 cell transplantation. We find that StrainSifter is able to identify strains of both intestinal mucosa-83 
Sample processing 114
Bloodstream bacterial isolates were plated on brain heart infusion agar with 10% horse blood. DNA was 115 extracted from isolates using the Gentra Puregene Yeast/Bact. Kit per manufacturer's instructions. Stool 116 samples were collected and stored at 4°C for up to 24 hours prior to homogenization, aliquoting and 117 storage at 80°C. DNA was extracted from stool using the QIAamp DNA Stool Mini Kit (QIAGEN®) per 118 manufacturer's instructions, with an initial bead-beating step prior to extraction using the Mini-119
Beadbeater-16 (BioSpec Products) and 1 mm diameter Zirconia/Silica beads (BioSpec Products). Bead-120 beating consisted of 7 rounds of alternating 30 second bead-beating bursts followed by 30 seconds 121 cooling on ice. DNA concentration for all samples was measured using Qubit® Fluorometric Quantitation 122 (Life Technologies). DNA sequencing libraries from both isolates and stool were prepared using the 123 Nextera XT DNA Library Prep Kit (Illumina®) with isolates and stool microbiota libraries prepared at 124 separate times following DNAse treatment of all lab surfaces to avoid cross-contamination. Library 
Phylogenetic tree building and variant identification with the StrainSifter pipeline 150
StrainSifter is a pipeline deployed via Snakemake with modules for variant calling and phylogenetic tree 151 building, available at GitHub (https://github.com/bhattlab/strainsifter). StrainSifter accepts as input an 152 assembled bacterial draft genome and two or more short read data sets (isolate or metagenomic), and can 153 report a phylogenetic tree of input samples as well as pairwise SNV counts. To build the phylogenetic 154 trees reported in this manuscript, an NCBI RefSeq reference genome for each infectious species (based on clinical laboratory classifications) was provided to StrainSifter. For the variant counting reported herein, 156 BSI draft genomes were supplied to StrainSifter. For both analyses, all stool and BSI short read datasets 157 were provided as input. For both phylogeny and SNV-counting modules, preprocessed short reads are 158 first aligned to the reference genome using the Burrows-Wheeler aligner (BWA) v0.7.10 (Li and Durbin For phylogenetic tree construction, reads with 5 or fewer mismatches were included; for determining 164 strain single-nucleotide variants, reads were limited to 1 or fewer mismatches. Per-base coverage is 165 calculated from each resulting BAM file using bedtools genomecov (v2.26.0) and processed with custom 166 python scripts to identify samples meeting a minimum average coverage of 5X across at least 50% of the 167 genome. Only samples meeting the coverage requirement are continued through the pipeline. Pileup files 168 are created from BAM files using SAMtools "mpileup", and are analyzed using custom python scripts to 169 identify bases occurring with at least 0.8 frequency at positions covered 5X or greater. Only bases with a 170 minimum phred score of >=20 are considered. Consensus sequences for each sample are created, wherein 171 bases that cannot be confidently determined given the described parameters are called as "N". 172
173
To create a phylogenetic tree, core positions are identified on a per-species basis, where core positions are 174 defined as positions in the reference genome where a base could be confidently called for all samples 175 analyzed. To generate phylogenetic trees, core positions with variants in at least one sample are identified 176 and concatenated into fasta files. Fasta files are aligned using MUSCLE v3.8.31 (Edgar 2004 ) and a 177 maximum-likelihood phylogenetic tree is computed using FastTree v2.1.7 (Price, Dehal, and Arkin 2010). 178
Phylogenetic trees are visualized in R using the ape, phangorn, and ggtree packages. Pairwise SNVs are 179 determined from the consensus sequences using a custom python script. 180
Synthetic multilocus sequence typing 182
Metagenomic short reads were assembled using metaSPAdes v3.8.0 (Nurk et al. 2017 ). Multilocus 183 sequence typing (MLST) schemes and sequences were downloaded from the PubMLST database 184 ("PubMLST" n.d.). MLST gene sequences were aligned to metagenome assemblies, and the top hit for 185 each alignment was chosen based on E-value, percent identity, and alignment length. Only MLST 186 sequences that were present in the metagenomic assembly with 100% identity across the entire length of 187 the sequence were reported. MLST types generated by our in-house analysis were confirmed with the 188 SRST2 synthetic multilocus sequence typing tool (Inouye et al. 2014) . 189 190
Plots 191
Plots were generated using the R programming language using the ggplot2, reshape2, and dplyr packages. 
Sample collection and cohort 195
During the study period, we identified 74 patients within our stool biospecimen collection with a 196 bloodstream infection (77 BSI episodes). Of these, we identified 30 patients (32 bloodstream isolates) 197 with at least 1 collected stool sample within 30 days prior to their bacterial BSI. From our final cohort of 198 30, we sequenced all stool samples collected between 60 days prior to and 30 days after the date of BSI, 199 83 samples in total. Patients had a median of 2 stool samples (range 1-8), with the sampling distribution 200 presented in Figure 1 . Stools were collected at a median of 9 days prior to BSI (range -58 to +31). 201
Clinical characteristics of the 30 patients are listed in Table 1 (see Table S1 for individual patient data). 202
All patients in the cohort were on at least one antibiotic within 30 days prior to BSI, with 203 fluoroquinolones being the most commonly administered antibiotic. (Table S2 ). Isolate reads were assembled into draft genomes 220 (Table S3) . 221 222 MALDI-TOF is unable to discriminate between some closely related taxa (e.g. Streptococcus spp.), so we 223 sought to confirm the clinical laboratory BSI classifications by aligning draft genome contigs to the 224 BLAST nt database. Of 32 BSIs, we identified 3 for which WGS and MALDI-TOF results disagreed. 225
Two Streptococcus isolates that had been classified as Streptococcus mitis by MALDI-TOF were 226 identified as Streptococcus oralis, and one as Streptococcus pseudopneumoniae by WGS (Table S4) . 227
228
To determine community composition of pre-and post-BSI stool samples, we taxonomically classified 229 gut metagenomic reads via the One Codex platform. Considering species level read classifications, we 230 observe the target species in the gut at a threshold of 0.1% or greater relative abundance for 19 of 83 231 stools (23%) or 20 of 95 stool-BSI pairs (21%) taking into account episodes of polymicrobial BSI; one 232 patient developed a BSI with two bacterial species, both of which were present in the stool above 233 threshold level ( 
Gut domination with an infectious pathogen does not always precede bloodstream infection 242
We sought to determine whether bloodstream infection is preceded by gut microbiota domination by a 243 pathogen as has been previously reported (Ubeda et al. 2010; Taur et al. 2012 ). We defined domination as 244 30% species relative abundance or greater of an organism in the gut, as previously described (Taur et al. 245 2012) . Of the 19 stools in which the BSI organism was detected, only 4 stool samples (21%) were 246 dominated by the BSI pathogen. Stool samples from patient 3 were dominated by Escherichia coli (>85% 247 relative abundance) 27, 32, and 33 days prior to the development of an E. coli BSI (Figure 2A; table 2) ; 248
Enterococcus faecium dominated the intestinal microbiome (94% relative abundance) in patient 25 three 249 days after E. faecium BSI ( Figure 2B; table 2) . BSI, yet stool samples at two timepoints were dominated by other pathogens: E. coli at 67% relative 259 abundance 9 days prior to BSI and E. faecium at 85% relative abundance 19 days after BSI (Table 2) . 
Phylogenetic analysis indicates close relatedness of gut and BSI strains 269
We developed the StrainSifter pipeline to perform nucleotide-level comparisons between genomes and 270 metagenomes. StrainSifter is deployed as a Snakemake workflow, and the pipeline steps are described in 271 Figure 3 . Briefly, the inputs to StrainSifter are a draft genome (the "target" genome) and one or more 272 other short read datasets (isolate genomes or metagenomes). StrainSifter detects whether the target 273 organism is present with sufficient abundance in the short read datasets and outputs phylogenetic trees 274 and SNV counts between samples. Despite an abundance of research studies focused on strain-level 275 comparisons of microbes, there is still no clear definition of what constitutes a "strain," and it is unclear 276 whether genomes that differ by a few nucleotides should be considered distinct strains. To investigate the 277 overall relatedness of strains of each BSI species in our metagenomes and isolates, we first took a 278 comparative phylogenomics approach by applying StrainSifter to assess inter-patient strain relatedness. 279
Rather than compare strains from the same patient to publicly-available reference genomes, we instead 280 compared the phylogenetic relatedness of a patient's gut and BSI strains to strains from the other patient 281 samples in our collection. We reasoned that strains from the same geographic location are more likely to 282 be closely phylogenetically related than strains that are both spatially and temporally distant, so 283 
Single-nucleotide variants reveal strain identity
We next used StrainSifter to compare single-nucleotide variants (SNVs) between strains in our sample 304 collection. We executed the StrainSifter pipeline for each draft genome, with all stool short read datasets 305 as input. StrainSifter identified samples with sufficient coverage (at least 5X coverage across 50% or 306 more of the genome) of the target organism in the gut metagenome and determined the number of variants 307 shared between each pair of input samples that contained the target strain. 308
309
We observe 1 SNV between the BSI and gut content of Patient 13 who developed a S. epidermidis BSI 310 (Table 3 ). This indicates that the bloodstream strain is concordant to the strain found in the gut 1 day 311 prior. Patient 3 developed an E. coli bloodstream infection and we observe zero SNVs between the BSI 312 strain and all samples 33, 32, and 27 days prior to the BSI, indicating that the identical E. coli BSI strain 313 colonized the gut over a month before the onset of infection. Further, we observe zero discriminating 314
SNVs between identical strains of Pseudomonas aeruginosa in both the blood and stool specimens. 315
Notably, all stool samples containing the BSI-causing organism at sufficient coverage to profile with 316
StrainSifter were more closely related to their respective BSI isolate based on SNV distance than to any 317 sample from other patients. None of the 30 patients included in our study had sufficient Staphylococcus 318 aureus in their stool samples to profile with StrainSifter, indicating that this organism infrequently 319 colonizes the gut of HCT patients, even at low abundance. 320 321 
In silico multilocus sequence typing is concordant with StrainSifter results 331
To compare whole-genome sequencing-based approaches to traditional strain typing methods, we 332 performed in silico multilocus sequence typing (MLST) on BSI genomes and assembled stool 333 metagenomes (Table 3) . In many instances, MLST types for gut metagenome strains could not be 334 resolved or could only be partially detected, likely due to low abundance or absence of the target 335 organism in the gut community. MLST data is concordant with StrainSifter SNV profiling in only 4 336 infections for which MLST schemes exist for the bloodstream isolate of interest (Table S7 ). MLST types 337 could not be determined for either of patient 2's BSI isolates (K. pneumoniae and E. cloacae) because the 338 sequences at several loci in each genome were not present in the respective MLST databases. We were 339 unable to type Rothia mucilaginosa and Streptococcus mitis, as standard MLST schemes do not exist for 340 these organisms. High resolution strain comparisons are required to identify the origins of bloodstream infections using 346 metagenomic samples. While many bioinformatic tools exist for strain comparison between clinical 347 isolates or SNV profiling between metagenomes, no pipeline exists for the specific purpose of detecting 348 the presence of a single strain in a metagenome. In this study, we have developed StrainSifter, a 349 straightforward and facile pipeline for identifying phylogenetic relationships between isolate and 350 metagenomic WGS samples. well described. In our own study, multiple stool samples were determined to have more than 80% relative 377 abundance of S. epidermidis. In addition, we observe the same colonizing strain of coagulase-negative 378 are not considered to be the same. Regardless of the absolute number of SNVs between strains or across 400 all strains analyzed with StrainSifter, strains from the same patient consistently share fewer SNVs 401 compared to those from other patients. 402
403
Although StrainSifter can precisely identify shared variants between genomes and metagenomes, it is 404 limited to profiling only the dominant strain of a given organism in a community. However, it has been 405 shown that gut metagenomes frequently contain only one predominant strain of each species, so 406
StrainSifter is likely to function optimally in most situations (Truong et al. 2017) . As is the case with 407 existing tools for metagenomic strain comparison, StrainSifter is unable to analyze low-abundance strains 408 since adequate coverage (5X) is required for confident variant calling. 409
Future directions 411
StrainSifter can be used to precisely identify strains within relatively biomass-rich metagenomic samples 412 without relying on external reference genome databases in which representation of opportunistic 413 pathogens may be lacking. Compared to stool, samples from the nares, skin, or the environment typically 414 have far less microbial biomass, limiting the number of sequencing reads that can be obtained. In order to 415
provide the most precise epidemiologic information about the origins of bloodstream and other infections, 416
StrainSifter will need to be tested in low microbial biomass samples in a larger prospective study of 417 immunocompromised patients. Given the high resolution of WGS-based strain comparisons, we may 418 indeed discover instances of organisms thought to originate from non-enteric sites instead colonizing and 419 translocating from the intestine in severely immunocompromised patients, as was potentially 420 demonstrated by S. epidermidis and P. aeruginosa in our study. Given the growing body of research on 421 therapies to improve gut microbiota diversity and bolster colonization resistance against pathogens, more 422 precisely identifying the origins of bloodstream infections in the stem cell transplant population may 423 influence how hospitals and healthcare providers can most effectively work to prevent infections 424 (Galloway-Peña, Jenq, and Shelburne 2017). Finally, once StrainSifter is able to establish the origins of 425 an infection, the wealth of information offered by WGS can be interrogated to identify potential 426 functional differences, including in gene content and metabolic pathways, between strains colonizing the 427 gut, nares, or skin that result in disseminated infections compared to those that do not. 428
429
In conclusion, we have shown that StrainSifter offers a straightforward bioinformatic pipeline to precisely 430 compare bacterial isolates to metagenomic samples, circumventing the need for external reference 431 genome databases or culture-based methods of strain comparison. We successfully applied StrainSifter to 432 blood culture isolates and stool samples from hematopoietic stem cell transplant patients and found 433 classically non-enteric bacteria in the gut microbiome that were concordant with bloodstream isolates. We 434 anticipate that StrainSifter will be an easy-to-use tool in the context of hospital or infectious outbreak 435 epidemiologic studies, and that characterization of the microbiome dynamics that occur prior to infection 436 may help us precisely identify potential reservoirs of pathogens. 437
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